O Shaughnessy Asset Management LLC Sells 1,243 Shares of McKesson Co. (NYSE:MCK)

O Shaughnessy Asset Management LLC lessened its position in shares of McKesson Co. (NYSE:MCK - Free Report) by 2.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,920 shares of the company's stock after selling 1,243 shares during the quarter. O Shaughnessy Asset Management LLC's holdings in McKesson were worth $29,020,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of McKesson during the 4th quarter valued at $1,200,361,000. Janus Henderson Group PLC grew its stake in shares of McKesson by 126.8% during the third quarter. Janus Henderson Group PLC now owns 574,440 shares of the company's stock worth $283,903,000 after purchasing an additional 321,119 shares during the period. Proficio Capital Partners LLC bought a new stake in McKesson in the fourth quarter valued at about $178,397,000. Raymond James Financial Inc. acquired a new position in McKesson in the fourth quarter valued at about $128,125,000. Finally, Boston Partners boosted its holdings in McKesson by 24.6% during the fourth quarter. Boston Partners now owns 1,096,301 shares of the company's stock worth $625,501,000 after buying an additional 216,432 shares during the last quarter. Institutional investors own 85.07% of the company's stock.

Insider Transactions at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of the business's stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the transaction, the chief executive officer now owns 60,664 shares of the company's stock, valued at $36,276,465.36. The trade was a 12.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Leann B. Smith sold 188 shares of the firm's stock in a transaction that occurred on Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the sale, the executive vice president now directly owns 1,051 shares of the company's stock, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 18,689 shares of company stock worth $11,187,351 in the last 90 days. Corporate insiders own 0.11% of the company's stock.

Remove Ads

McKesson Trading Up 3.0 %

Shares of NYSE MCK traded up $20.43 during midday trading on Wednesday, reaching $694.12. The company's stock had a trading volume of 1,203,109 shares, compared to its average volume of 830,700. The stock has a 50 day simple moving average of $626.97 and a 200-day simple moving average of $582.06. The stock has a market capitalization of $86.99 billion, a price-to-earnings ratio of 31.78, a PEG ratio of 1.29 and a beta of 0.52. McKesson Co. has a fifty-two week low of $464.42 and a fifty-two week high of $695.46.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. As a group, equities analysts anticipate that McKesson Co. will post 32.77 EPS for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd were given a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 0.41%. The ex-dividend date of this dividend was Monday, March 3rd. McKesson's dividend payout ratio (DPR) is 13.00%.

Analysts Set New Price Targets

MCK has been the topic of a number of analyst reports. StockNews.com downgraded shares of McKesson from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Wells Fargo & Company increased their target price on shares of McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a report on Friday, March 14th. Mizuho started coverage on shares of McKesson in a report on Wednesday, December 4th. They issued a "neutral" rating and a $630.00 price target for the company. Evercore ISI raised their price objective on McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research note on Thursday, February 6th. Finally, Citigroup decreased their target price on McKesson from $713.00 to $677.00 and set a "buy" rating for the company in a research note on Friday, January 10th. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, McKesson has a consensus rating of "Moderate Buy" and an average target price of $656.71.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.